Clinical Trial Update: Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections [Phase 2]

View source ↗

Summary

Pfizer reports Phase 2 results from a comparative trial of NXL104 combined with ceftazidime versus a comparator in adults with complicated urinary tract infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection

Drugs mentioned

• NXL104 (NXL104)
• ceftazidime (ceftazidime)

Snippet

Sponsor: Pfizer | Conditions: Complicated Urinary Tract Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-05-25